Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V0HM
|
||||
Former ID |
DNC006420
|
||||
Drug Name |
Adp[-Trp-Arg-Nva-Arg-Tyr-NH2]2
|
||||
Indication | Discovery agent | Investigative | [528136] | ||
Structure |
Download2D MOL |
||||
Formula |
C80H118N28O14
|
||||
Canonical SMILES |
CCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)<br />NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(C<br />CC(C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CCCN=C(N)N)C(=O)N<br />C(CCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)N<br />)N)N
|
||||
InChI |
1S/C80H118N28O14/c1-3-13-55(69(115)101-59(21-11-35-95-79(89)90)73(119)105-61(65(83)111)37-43-23-27-47(109)28-24-43)99-71(117)57(19-9-33-93-77(85)86)103-75(121)63(39-45-41-97-53-17-7-5-15-49(45)53)107-67(113)51(81)31-32-52(82)68(114)108-64(40-46-42-98-54-18-8-6-16-50(46)54)76(122)104-58(20-10-34-94-78(87)88)72(118)100-56(14-4-2)70(116)102-60(22-12-36-96-80(91)92)74(120)106-62(66(84)112)38-44-25-29-48(110)30-26-44/h5-8,15-18,23-30,41-42,51-52,55-64,97-98,109-110H,3-4,9-14,19-22,31-40,81-82H2,1-2H3,(H2,83,111)(H2,84,112)(H,99,117)(H,100,118)(H,101,115)(H,102,116)(H,103,121)(H,104,122)(H,105,119)(H,106,120)(H,107,113)(H,108,114)(H4,85,86,93)(H4,87,88,94)(H4,89,90,95)(H4,91,92,96)/t51?,52?,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-/m0/s1
|
||||
InChIKey |
TWBRLXCGQXCXSU-DGGARAOESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Neuropeptide Y receptor type 4 | Target Info | Inhibitor | [528136] | |
Neuropeptide Y receptor type 2 | Target Info | Inhibitor | [528136] | ||
Neuropeptide Y receptor type 1 | Target Info | Inhibitor | [528136] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.